The present study assessed the association between the serum apoB/A-I ratio and CAC according to kidney function status in a large number of healthy subjects without a previous history of CVD or other confounding risk factors for CVD, including diabetes, hypertension, or dyslipidemia. Here, APOB is linked to metabolic syndrome.